Swiss National Bank

Bank

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in SYRE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$9,987,750

+$5,120,290 QoQ

Shares Held

112,500

+16.6% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#73

of 266 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. SYRE ranks #34 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,987,750	112,500	+16.6%	Shares	Sole	2026-08-11
2026-03-31	$4,867,460	96,500	0.0%	Shares	Sole	2026-05-07
2025-12-31	$3,161,340	96,500	+37.5%	Shares	Sole	2026-02-12
2025-09-30	$1,176,552	70,200	+2.3%	Shares	Sole	2025-11-13
2025-06-30	$1,026,942	68,600	0.0%	Shares	Sole	2025-08-12
2025-03-31	$1,106,861	68,600	0.0%	Shares	Sole	2025-05-12
2024-12-31	$1,597,008	68,600	+38.3%	Shares	Sole	2025-02-10
2024-09-30	$1,458,736	49,600	+37.4%	Shares	Sole	2024-11-07
2024-06-30	$848,711	36,100	-7.7%	Shares	Sole	2024-08-08
2024-03-31	$1,483,063	39,100	—	Shares	Sole	2024-05-07
No filing history on record for this holder in this stock.